Acme United (ACU)

Acme United Corp. is engaged in the supply of cutting devices, measuring instruments, and safety products for school, home, office, hardware and industrial use. It offers its products under Camillus, Clauss, Cuda, DMT Sharpeners, First Aid Only, Pac-Kit, Physicianscare, Spill Magic, Westcott and Western brands. The company was founded in 1867 and is headquartered in Fairfield, CT.

Company profile

Walter C. Johnsen
Fiscal year end
The Company • Acme United Limited • Acme United Europe GmbH • Acme United (Asia Pacific) Limited • Acme United China Limited ...
IRS number

ACU stock data


8 Aug 22
20 Aug 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 3.26M 3.26M 3.26M 3.26M 3.26M 3.26M
Cash burn (monthly) 682.33K (no burn) (no burn) (no burn) (no burn) 14.45K
Cash used (since last report) 1.15M n/a n/a n/a n/a 24.34K
Cash remaining 2.11M n/a n/a n/a n/a 3.24M
Runway (months of cash) 3.1 n/a n/a n/a n/a 223.9

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
8 Aug 22 Johnsen Walter C Common Stock Sale back to company Dispose D No No 28.82 11,078 319.27K 308,820
8 Aug 22 Johnsen Walter C Common Stock Option exercise Acquire M No No 13.75 15,000 206.25K 319,898
8 Aug 22 Johnsen Walter C Stock Option Common Stock Option exercise Dispose M No No 13.75 15,000 206.25K 450,500
3 Aug 22 Olschan Brian S Employee Stock Option Common Stock Grant Acquire A No No 29.35 25,000 733.75K 359,961
3 Aug 22 Johnsen Walter C Employee Stock Option Common Stock Grant Acquire A No No 29.35 30,000 880.5K 465,500
3 Aug 22 Driscoll Paul G Employee Stock Option Common Stock Grant Acquire A No No 29.35 15,000 440.25K 176,000
29 Jul 22 Davidson Rex Lynn Common Stock Buy Acquire P No No 31.6 275 8.69K 975
60.2% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 32 36 -11.1%
Opened positions 0 2 EXIT
Closed positions 4 4
Increased positions 8 12 -33.3%
Reduced positions 13 11 +18.2%
13F shares Current Prev Q Change
Total value 71.58M 72.26M -0.9%
Total shares 2.12M 2.14M -1.1%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Capital Management 487.4K $16.45M +4.8%
North Star Investment Management 399.04K $13.47M -0.2%
Dimensional Fund Advisors 175.31K $5.92M -0.2%
Renaissance Technologies 163.61K $5.52M -6.3%
FIL 141.47K $4.78M 0.0%
Royce & Associates 129.48K $4.37M -4.8%
Bard Associates 124.65K $4.21M 0.0%
Vanguard 123.51K $4.17M -0.9%
Mork Capital Management 70K $2.36M 0.0%
Bridgeway Capital Management 67.22K $2.27M -10.1%
Largest transactions Shares Bought/sold Change
Capital Management 487.4K +22.22K +4.8%
Navellier & Associates 0 -15.93K EXIT
Renaissance Technologies 163.61K -11K -6.3%
Bridgeway Capital Management 67.22K -7.52K -10.1%
Royce & Associates 129.48K -6.58K -4.8%
RY Royal Bank Of Canada 7.34K -4.25K -36.7%
TETAA Teton Advisors 55K -2K -3.5%
Acadian Asset Management 19.87K +1.38K +7.5%
Diamond Hill Capital Management 9.04K +1.35K +17.6%
MS Morgan Stanley 1.92K +1.23K +177.2%

Financial report summary

  • The Company is subject to a number of significant operational risks that might cause the Company’s actual results to vary materially from its forecasts, targets or projections, including:
  • If we identify a material weakness in our internal controls over financial reporting, such material weakness could result in material misstatements in our financial statements.
  • Because our products are primarily sold by third parties, our financial results depend in part on the financial health of these parties and any loss of a third-party distributor could adversely affect the Company’s revenues.
  • The ability to deliver products to our customers in a timely manner and to satisfy our customers’ fulfillment standards are subject to many factors, some of which are beyond our control. These factors presently include the impact of supply chain issues and the COVID-19 pandemic on the Company.
  • Matters relating to the employment market and prevailing wage standards may adversely affect our business.
  • The Company’s business is subject to risks associated with seasonality which could adversely affect its cash flow, financial condition, or results of operations.
  • Failure to manage growth and continue to expand our operations successfully could adversely affect our financial results.
  • Unfavorable shifts in industry-wide demand for the Company’s products could result in inventory valuation risk.
  • Loss of a major customer could result in a decrease in the Company’s future sales and earnings.
  • The loss of key management could adversely affect the Company’s ability to run its business.
  • Execution or the lack thereof, of our e-commerce business may reduce our operating results.
  • The Company may not be able to maintain or to raise prices in response to increasing costs or inflation.
  • The Company is subject to intense competition in all of the markets in which it competes.
  • Compromises of our information systems or unauthorized access to confidential information or our customers' or associates' personal information may materially harm our business or damage our reputation.
  • The Company may need to raise additional capital to fund its operations.
  • Failure to protect the Company’s proprietary rights or the costs of protecting these rights could adversely affect its business.
  • If the Company is found to have infringed the intellectual property rights of others or cannot obtain necessary intellectual property rights from others, its competitiveness could be negatively impaired.
  • Product liability claims or regulatory actions could adversely affect the Company's financial results and reputation.
  • The Company’s businesses and operations are subject to regulation in the U.S. and abroad.
  • Certain or our products and facilities are subject to regulation by the FDA and by analogous foreign regulators.
  • The Company is subject to environmental regulation and environmental risks.
  • The Company’s operations are increasingly global in nature. Our business, financial condition and results of operations could be adversely affected by the political and economic conditions in the countries in which we conduct business, by fluctuations in currency exchange rates and other factors related to our international operations.
  • Reliance on foreign suppliers could adversely affect the Company’s business.
  • Continuing uncertainty in the global economy could negatively impact our business.
  • Changes in trade policies, including the imposition of tariffs and their enforcement, may have a material adverse impact on our business, results of operations, and outlook.
  • The economic effects of the COVID-19 pandemic and measures taken to arrest its spread, as well as measures we have taken and continue to take in response to the pandemic, could adversely impact our business, including our operating results, financial condition and liquidity.
  • Vaccine mandates applicable to us could have a material adverse impact on our business and results of operations.
  • We cannot provide assurance that we will continue to pay dividends or purchase shares of our common stock under our stock repurchase programs.
  • Our shares of common stock are thinly traded and our stock price may be volatile.
Management Discussion
  • The Company may from time to time make written or oral “forward-looking statements” including statements contained in this report and in other communications by the Company, which are made in good faith pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our beliefs as well as assumptions made by and information currently available to us. When used in this document, words like “may,” “might,” “will,” “except,” “anticipate,” “believe,” “potential,” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from our current expectations.
  • Forward-looking statements in this report, including without limitation, statements related to the Company’s plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties that may impact the Company’s business, operations and financial results, including those risks and uncertainties resulting from the global COVID-19 pandemic, future waves of COVID-19, including through the Delta and Omicron variants and any new variant strains of the underlying virus; any future pandemics; the continuing effectiveness, global availability, and public acceptance of existing vaccines; the effectiveness, availability, and public acceptance of vaccines against variant strains of potential new viruses; and the heightened impact the pandemic has on many of the risks described herein, including, without limitation, risks relating to disruptions in our domestic and global supply chains, and labor shortages, any of which could materially adversely impact the Company’s ability to manufacture, source or distribute its products, both domestically and internationally.
  • These risks and uncertainties further include, without limitation, the following: (i) changes in the Company’s plans, strategies, objectives, expectations and intentions, which may be made at any time at the discretion of the Company; (ii) the impact of uncertainties in global economic conditions, whether caused by COVID-19 or otherwise, including the impact on the Company’s suppliers and customers; (iii) additional disruptions in the Company’s supply chains, whether caused by COVID-19, the war in Ukraine, or otherwise, including trucker shortages, port closures and delays, and delays with container ships themselves; (iv) labor shortages and related costs the Company has and may continue to incur, including costs of acquiring and training new employees and rising wages and benefits; (v) the continuing adverse impact of inflation, including product costs, and transportation costs; (vi) currency fluctuations including, for example, the increasing strength of the dollar against the euro: the Company’s ability to effectively manage its inventory in a rapidly changing business environment, including the additional inventory the Company has acquired in anticipation of supply chain disruptions and uncertainties; (vii) changes in client needs and consumer spending habits; (viii) the impact of competition; (ix) the impact of technological changes including, specifically, the growth of online marketing and sales activity; (x) the Company’s ability to manage its growth effectively, including its ability to successfully integrate any business it might acquire; (xi) international trade policies and their impact on demand for our products and our competitive position, including the imposition of new tariffs or changes in existing tariff rates; and (xiii) other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission.

Content analysis

8th grade Avg
New words: carryover, Coast, combination, contingent, disclosed, East, EBITDA, escrow, euro, finalization, funded, intangible, Keene, leading, liability, List, Live, LLC, month, NH, percentage, preliminary, range, slowdown, SOFR, trucker, Ukraine, unfilled, valuation, war, West
Removed: Central, decrease, hiring, lower, Prime, tangible, worth, xii